SIGLEC15 Antikörper (AA 22-319) (APC)
Kurzübersicht für SIGLEC15 Antikörper (AA 22-319) (APC) (ABIN8037183)
Target
Alle SIGLEC15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 22-319
-
Verwendungszweck
- Anti-SIGLEC15 Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human SIGLEC15 recombinant protein (Position: R22-R319).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- SIGLEC15 (Sialic Acid Binding Ig-Like Lectin 15 (SIGLEC15))
-
Andere Bezeichnung
- SIGLEC15
-
Hintergrund
-
Background: Predicted to be involved in regulation of actin cytoskeleton organization, regulation of bone resorption, and regulation of osteoclast development. Predicted to be located in membrane. Predicted to be part of protein-containing complex. Predicted to be active in plasma membrane.
Gene Full Name: sialic acid binding Ig like lectin 15
-
Gen-ID
- 284266
-
UniProt
- Q6ZMC9
Target
-